May 25, 2023 | Vensana Capital® Portfolio News

Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A